Hemp, Inc. Settles Longstanding Lawsuit With Securities And Exchange Commission

NEVADA:  Hemp, Inc. announced that it has settled the longstanding 5-year old SEC civil case. Hemp, Inc. and Bruce Perlowin have agreed to settle the civil suit against them without admitting or denying the SEC’s allegations. Perlowin is transitioning from CEO to Chief Visionary Consultant (CVC) and will not be managing the day-to-day tasks of the company. He will, however, remain as the true visionary Hemp, Inc. shareholders have come to admire and respect.

The Company remains committed to its longstanding goals and will be aggressively moving forward to add new blood and new ideas to the management of the company. In the first quarter 2021, Hemp, Inc. will expand its knowledge base by bringing in a new CEO and new members of its Board of Directors.

Tilray Launches Initial Public Offering

CANADA: Tilray, a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor, announced that it has launched an initial public offering of its Class 2 common stock pursuant to a registration statement on Form S-1 previously filed with the United States Securities and Exchange Commission. Tilray has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol “TLRY”.

 

Agreement represents major milestone recognizing medical cannabis as a conventional medicine for patients in need

Tilray is offering 9,000,000 shares of Class 2 common stock at an initial price to the public between US$14.00 and US$16.00 per share (approximately CAD$18.40 to CAD$21.00 per share1). Tilray intends to grant the underwriters a 30-day over-allotment option to purchase up to 1,350,000 additional shares.

In order to qualify the offering of securities in Canada and to ensure that purchasers in Canada are not subject to restrictions on resale, Tilray has also filed a preliminary prospectus for a proposed IPO in Canada with the securities regulatory authorities in each province of Canada other than the Province of Quebec. Tilray does not intend to list on any stock exchange in Canada.

Cowen and BMO Capital Markets are acting jointly as book-runners for the proposed IPO. Cowen is acting as the sole book-running manager for the IPO in the United States, and BMO Capital Markets is acting as the sole book-running manager for the IPO in Canada. Eight Capital is acting as lead manager for the IPO in Canada. In the United States, Roth Capital Partners is acting as lead manager and Northland Capital Markets is acting as a co-manager for the IPO.

The offering will be made only by means of a prospectus. Copies of the U.S. preliminary prospectus may be obtained from the SEC’s website or from Cowen by contacting Cowen c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department. Phone: (631) 274-2806. Copies of the Canadian preliminary prospectus may be obtained from www.sedar.com or from BMO Capital Markets by contacting BMO Capital Markets, Brampton Distribution Centre c/o The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario, L6S 6H2 or by telephone at (905) 791-3151 Ext 4312 or by email at torbramwarehouse@datagroup.ca.

A registration statement on Form S-1 relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

1Based approximately on the Bank of Canada daily exchange rate on July 5, 2018 of C$1.3129 = US$1.00

Top Three Best Performing Cannabis Stocks Over The Past Year

CALIFORNIA: SECFilings.com, a financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering the top three best performing stock of the past year. Companies discussed are AXIM Biotechnologies (OTCQB: AXIM), Supreme Pharmaceuticals, and American Cannabis.

#1: AXIM Biotech (+2,445.61%)

AXIM Biotechnologies Inc. (OTCQB: AXIM) is focused on developing a portfolio of over 20 cannabinoid-based pharmaceuticals and nutraceuticals along with 17 patents and 20 trademarks. The company’s flagship products utilize its proprietary chewing gum-based delivery system to provide consumers with superior bioavailability without the negative side effects or stigma of smoking cannabis or taking consuming edibles.

In recent months, the company began early-stage clinical trials of its CanChew Plus for the treatment of irritable bowel syndrome (“IBS”), as well as CanChew Rx for treatment of pain and spasticity in Multiple Sclerosis (MS) patients which is projected to reach a market size of $20 billion by 2024. In addition to those programs, AXIM recently announced a partnership with a US API company to develop an alternative generic version of FDA-approved Marinol® as reported by Forbes. These clinical programs represent multi-billion dollar markets where cannabinoids could prove beneficial in providing patients with much-needed relief.

#2: Supreme Pharmaceuticals (+286.44%)

Supreme Pharmaceuticals Inc. is a one of about 40 licensed producers of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations — or ACMPR. The company’s 7-acre — 342,000 square foot — hybrid greenhouse combines the best practices of indoor cultivation with the cost structure of a greenhouse to produce high-quality marijuana at a low cost.

Unlike many other licensed producers, the company is focusing exclusively on the business-to-business market where it will employ a wholesale business model. The company anticipates that the greenhouse will be capable of producing over 50 million grams of cannabis per year at full capacity. Its next buildout will bring on an additional 80,000 square feet of production space in addition to the 40,000 square feet that’s already operational.

#3: American Cannabis (+173.5%)

American Cannabis Co. is a business-to-business consulting firm and distributor of ancillary products and services to the cannabis industry. The company offers turnkey end-to-end solutions to existing and aspiring businesses in the cannabis industry by leveraging its hands-on experience and knowledge to provide business planning, license procurement, and operational best practices.

Recently, the company announced that it secured its first retainer client in the State of Louisiana. CB Medical LLC engaged the company’s services as an applicant of the LSU-sponsored medical marijuana program. The two companies aim to design and operate a medical marijuana program for patients in Louisiana in partnership with the state’s leading university — complete with an indoor cultivation center and laboratory.

Please follow the link to read the full article: http://analysis.secfilings.com/articles/164-top-3-best-performing-cannabis-stocks

SEC Allows Pot Dealer To Register Stock

NEW YORK:  The U.S. Securities and Exchange Commission has allowed a share registration to proceed for a company whose business model includes cultivation and sale of marijuana, which are both illegal under federal law, though legal under some state laws.

This approval appears to be the first green light for a share registration by a company in this line of business and could set a precedent for marijuana dealers to access the equity markets, but the agency’s ambivalence about such a business model is clear from the way it handled the registration.

Irvine, Calif.-based Terra Tech Corp. TRTC, +2.35%   recently received approval for its disclosures and the registration of its shares.

Another company planning to cultivate and sell marijuana also has a pending application with the SEC, a source familiar with the company said.